Caribou Biosciences Class Action Submission Form

Company: Caribou Biosciences, Inc.

Ticker: (NASDAQ) CRBU

Deadline

Passed

Lead Plaintiff Deadline: April 11, 2023

Every year, thousands of shareholders miss deadlines to receive settlement funds. Make sure you don’t. Sign up for case alerts.

To receive more detailed alerts provide your information below.

Request Case Alerts

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.

Allegations

The filed complaint alleges that Caribou Biosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that:

(i) the treatment effect of the Company’s product candidate, CB-010, was not as durable as defendants had led investors to believe; (ii) accordingly, CB-010’s clinical and commercial prospects were overstated; and (iii) as a result, documents issued in connection with Caribou’s initial public offer and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.